Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | IMA402 |
Trade Name | |
Synonyms | IMA-402|IMA 402 |
Drug Descriptions |
IMA402 is a bispecific T-cell engaging receptor targeting an HLA-A*02-presented peptide derived from PRAME, which potentially leads to tumor cell killing and inhibition of tumor growth (Blood (2022) 140 (Supplement 1): 9089-9090). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
IMA402 | IMA402 | 0 | 1 |